Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-011750
Filing Date
2025-04-11
Accepted
2025-04-11 13:23:33
Documents
1
Period of Report
2025-04-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 2697
  Complete submission text file 0001437749-25-011750.txt   4407
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Issuer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address
SPENCER JOHN N JR (Reporting) CIK: 0001270555 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39563 | Film No.: 25830916